Celltrion
068270.KS
111,39 €
Share price
-0.03%
Change (1 day)
-16.39%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Cash on Hand
Cash on Hand as of December 2024 : €0.67 Billion
According to Celltrion
's latest financial reports the company has €0.67 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Celltrion - Cash on Hand chart (from 2007 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | €0.74 B | 41.31% |
| 2023-12-31 | €0.52 B | 20.53% |
| 2022-12-31 | €0.43 B | -51.45% |
| 2021-12-31 | €0.90 B | 73.23% |
| 2020-12-31 | €0.52 B | 7.83% |
| 2019-12-31 | €0.48 B | 16.3% |
| 2018-12-31 | €0.41 B | -4.46% |
| 2017-12-31 | €0.43 B | 101.71% |
| 2016-12-31 | €0.21 B | 78.23% |
| 2015-12-31 | €0.12 B | 36.39% |
| 2014-12-31 | €88.95 M | 14.49% |
| 2013-12-31 | €77.7 M | 3.42% |
| 2012-12-31 | €75.13 M | 92.92% |
| 2011-12-31 | €38.94 M | -52.53% |
| 2010-12-31 | €82.03 M | 515.61% |
| 2009-12-31 | €13.32 M | 452% |
| 2008-12-31 | €2.41 M | -22.64% |
| 2007-12-31 | €3.12 M |